Reclassification of Acute Respiratory Distress Syndrome: A Secondary Analysis of the ARDS Network Trials.
Pubmed ID: 29723056
Journal: Annals of the American Thoracic Society
Publication Date: Aug. 1, 2018
Affiliation: 2 University of Athens Medical School Athens, Greece.
MeSH Terms: Humans, Male, Adult, Female, Aged, Middle Aged, Randomized Controlled Trials as Topic, Treatment Outcome, Cause of Death, Severity of Illness Index, Mortality, Intensive Care Units, Respiration, Artificial, Length of Stay, Oxygen Inhalation Therapy, Oxygen, Partial Pressure, Respiratory Distress Syndrome
Authors: Oromendia C, Siempos II
Cite As: Oromendia C, Siempos II. Reclassification of Acute Respiratory Distress Syndrome: A Secondary Analysis of the ARDS Network Trials. Ann Am Thorac Soc 2018 Aug;15(8):998-1001.
Studies:
- Acute Respiratory Distress Network (ARDSNet) Studies 06 and 08 Prospective, Randomized, Multicenter Trial of Aerosolized Albuterol Versus Placebo for the Treatment of Acute Lung Injury (ALTA)
- Acute Respiratory Distress Network (ARDSNet) Studies 07, 08, 09, 11, and 12 Early Versus Delayed Enteral Feeding to Treat People with Acute Lung Injury or Acute Respiratory Distress Syndrome (EDEN)
- Acute Respiratory Distress Network (ARDSNet) Studies 10 and 12 Statins for Acutely Injured Lungs from Sepsis (SAILS)